A Study of RoActemra/Actemra (Tocilizumab) in Combination With Methotrexate Versus RoActemra/Actemra Monotherapy in Patients With Rheumatoid Arthritis and an Inadequate Response to Methotrexate

NCT01399697 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

261

Enrollment

INDUSTRY

Sponsor class

Conditions

Rheumatoid Arthritis

Interventions

DRUG: methotrexate
DRUG: methotrexate
DRUG: placebo
DRUG: tocilizumab [RoActemra/Actemra]

Sponsor

Hoffmann-La Roche